Kirin Holdings' Tender Offer for Fancl Concludes Successfully

Acquisition Strengthens Kirin's Health and Wellness Portfolio

Kirin Holdings Co., Ltd., a leading Japanese beverage and pharmaceutical company, announced the successful conclusion of its tender offer for Fancl Corporation, a prominent Japanese manufacturer of health foods and cosmetics. The tender offer, which commenced on October 3, 2022, and ended on November 14, 2022, resulted in Kirin acquiring approximately 90.2% of Fancl's outstanding shares.

Strategic Expansion for Kirin

The acquisition of Fancl aligns with Kirin's long-term strategy to expand its presence in the growing health and wellness market. Fancl's strong brand reputation, extensive product portfolio, and focus on natural and science-based products complement Kirin's existing offerings in the healthcare and functional food sectors. By combining the strengths of both companies, Kirin aims to create a comprehensive health and wellness platform that meets the evolving needs of consumers.

Fancl's Continued Growth and Innovation

Fancl will continue to operate as an independent subsidiary within the Kirin Group. The company's management team and employees will remain in place, ensuring continuity and stability in its operations. Kirin intends to support Fancl's ongoing growth and innovation efforts, leveraging its financial resources and distribution channels to expand its reach both domestically and globally.

Commitment to Quality and Customer Satisfaction

Kirin emphasizes that it will maintain Fancl's commitment to quality, safety, and customer satisfaction. The company will continue to adhere to Fancl's strict quality control standards and scientific approach to product development. Kirin believes that the acquisition will ultimately benefit consumers by providing them with a wider range of high-quality health and wellness products.

Industry Insights

The combination of Kirin and Fancl creates a formidable player in the health and wellness industry, with combined annual sales exceeding 1 trillion yen. Analysts expect the acquisition to enhance Kirin's competitive position in Japan and provide a platform for growth in international markets. The transaction also highlights the increasing convergence between the beverage, pharmaceutical, and health food industries as companies seek to meet the evolving needs of health-conscious consumers.

For more information, please visit Kirin's website at https://www.kirinholdings.com/ and Fancl's website at https://www.fancl.co.jp/